Aptorum Group Establishes Smart Pharma To Focus On Computational Repurposed Drug Discovery For Orphan And Unmet Diseases
SINGAPORE, April 24 (Bernama-BUSINESS WIRE) — Aptorum Group Limited (Nasdaq: APM) today announced the establishment of a new subsidiary group, Smart Pharma (“SmartP”), which operates its novel computational repurposed drug discovery, modeling and validation platform, together referred to as the “Smart-ACTTM” platform. Smart-ACTTM stands for Accelerated Commercialization of Therapeutics and encompasses state-of-the-art…

